Diabetic Macular Oedema (DME)

This is a Phase 4 progressive study of a treatment currently available to patients with macular oedema due to diabetic macular oedema (DME).

The Queensland Eye Institute is currently recruiting for patients with macular oedema due to diabetic macular oedema (DME). It is a Phase 4 progressive study of a treatment currently available to patients.

The aim of this trial is to show the treatment is able to reduce the progression of the condition and prevent related vision loss. Participants will receive a treatment injection in their

effected eyes for 12 months.

Principal Investigator Associate Professor Anthony Kwan.

Criteria

Inclusion Criteria

  • Participants aged 18 years and over.
  • Had cataract surgery or scheduled for a cataract operation.
  • Diagnosed with macular oedema in one or both eyes due to diabetic macular oedema DME.

Exclusion Criteria

  • Participation in another clinical trial or investigations involving treatment with an investigational drug or chemical within the past 6 months.
  • Participants using other concurrent intravitreal injections.
  • Women who are pregnant, nursing or childbearing potential without adequate contraception.

Talk with your doctor

To enable our ophthalmologist to confirm diagnosis, a referral from your optometrist, GP or ophthalmologist is required prior to registering your interest to participate in this study.

Age Range

18 years or older

Gender

All

Title of the video goes here

Lorem ipsum set emit dolor

Please support our sight saving work

Your support will help us recruit the best researchers to develop better treatments, purchase the latest equipment, advance clinical trials of new treatments, improve eye health education, and support talented students to become tomorrow’s leaders in eye research.

Make a donation